The Advertising Standards Agency (ASA) have begun an investigation
into Lloyds Pharmacy over suspicions they have been advertising
prescription-only medicines.
The advertising in question that raised the concerns was a newspaper
advert for a male impotence service offered by Lloyds Pharmacy. The ad
was labelled “lost the perk-in your gherkin”, depicting an image of a
drooping skyscraper, which left little to the imagination as to what the
picture was meant to be.
Accompanying this was an offer for an
erectile dysfunction pill that could be purchased online for £6,
suggesting this was a low price to patients.
According to section 12.12 of the UK Code of Non-broadcast
Advertising, Sales Promotion and Direct Marketing, prescription-only
medicines and prescription-only medical treatments are forbidden from
being advertised to the public.
The advert, currently being assessed by ASA’s Compliance team, was featured last month in London’s Evening Standard.
Pharmacist Cathryn Brown, spotted the advertisement and perhaps
justifiably deemed it to be “essentially an advert for a
prescription-only medicine”.
Speaking about her reasons for bringing the ad to the attention of
the ASA, Ms Brown said: “It’s a valuable thing to highlight awareness
that there are treatments available for erectile dysfunction and you
don’t have to go to your GP. But advertising it on the basis of price
per tablet doesn’t imply a professional service.”
What Ms Brown didn’t highlight is the fact the offer in the
advertisement is perhaps not as impressive as first seems. When you take
into account with Medical Specialists Pharmacy you can obtain Cialis Daily tablets (boxed in 28s) from as little as £2.92 each, or Sildenafil tablets
from as little as £4.12 each (both obtainable following a doctor’s
consultation and approval), maybe £6 per pill isn’t all it’s cracked up
to be.
The ASA replied to Ms Brown via an email last month, conceding the
pharmacist had made a “valid point”, adding there was a “clear issue”
with the fact the advert had broken advertising regulations. The ASA
said in the email that the case is now in the hands of their advertising
practice compliance team.
“The team will work to address the problem and ensure these ads,
where they appear to advertise prescription-only medicines rather than
the service generally, no longer appear,” the ASA said.
No comments:
Post a Comment